Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nam

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Rheumatology (Oxford, England)|September 18, 2016
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA studyLesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, et al.
Postgraduate Medical Journal|March 14, 2013
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritisEdith Villeneuve, Jackie L Nam, Mary J Bell, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritisEdith Villeneuve, Jackie L Nam, Mary J Bell, et al.
Rheumatology (Oxford, England)|June 11, 2026
T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practiceInnocent C Anioke, Fatih Tastekin, Gulay Alp, et al.
Rheumatology (Oxford, England)|July 23, 2019
Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritisIsabel Mortimer, Lesley-Anne Bissell, Elizabeth M A Hensor, et al.
BMJ Global Health|October 8, 2020
Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the COVID-19 pandemicKarl Blanchet, Ala Alwan, Caroline Antoine, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Rheumatology (Oxford, England)|March 3, 2019
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritisElizabeth M A Hensor, Paul McKeigue, Stephanie F Ling, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Rheumatology (Oxford, England)|September 18, 2016
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA studyLesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, et al.
Postgraduate Medical Journal|March 14, 2013
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritisEdith Villeneuve, Jackie L Nam, Mary J Bell, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritisEdith Villeneuve, Jackie L Nam, Mary J Bell, et al.
Rheumatology (Oxford, England)|June 11, 2026
T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practiceInnocent C Anioke, Fatih Tastekin, Gulay Alp, et al.
Rheumatology (Oxford, England)|July 23, 2019
Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritisIsabel Mortimer, Lesley-Anne Bissell, Elizabeth M A Hensor, et al.
BMJ Global Health|October 8, 2020
Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the COVID-19 pandemicKarl Blanchet, Ala Alwan, Caroline Antoine, et al.
Annals of the Rheumatic Diseases|August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)J L Nam, E Villeneuve, E M A Hensor, et al.
Rheumatology (Oxford, England)|March 3, 2019
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritisElizabeth M A Hensor, Paul McKeigue, Stephanie F Ling, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
Pageof 7